Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-17 5:00 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,698,348 16.200% | 89,999 (+5.60%) | View |
| 2024-05-06 4:05 pm Sale | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,608,349 19.300% | -26,666 (-1.63%) | View |
| 2024-03-19 4:10 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,635,015 21.000% | 135,000 (+9.00%) | View |
| 2024-03-15 12:13 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,500,015 19.500% | 144,906 (+10.69%) | View |
| 2024-03-06 5:05 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,355,109 18.300% | 86,666 (+6.83%) | View |
| 2023-06-21 5:05 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,268,443 20.100% | 112,835 (+9.76%) | View |
| 2022-12-29 5:20 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC CO LIPO | Kaufman Jonathan H | 1,155,608 18.600% | 1,155,608 (New Position) | View |